Age-related differences in TGF-α and proto-oncogenes expression in rat liver after a low dose of carbon tetrachloride

The resiliency of rats during early postnatal development to CCl₄ or to an interactive hepatotoxicity of chlordecone (CD) + CCl₄ has been shown to be due to an efficient stimulation of tissue repair. The objective of the current study was to investigate if this is due to efficient expression of transforming growth factor-α (TGF-α) and proto-oncogenes. Postnatally developing (20 day old) and adult (60 day old) male Sprague–Dawley rats were challenged with a single low dose of CCl₄ (100 μL/kg, ip) or corn oil. Liver samples were collected during a time course (0–96 h) after the administration of CCl₄ and used to examine TGF-α and early (c-fos) and late (H-ras and K-ras) proto-oncogenes mRNA expressions. Significant increases in TGF-α, H-ras, and K-ras gene expressions were evident as early as 12 hours after CCl₄ and peaked between 24 and 48 hours in an age-dependent manner as detected by slot-blot analysis. Results of the study revealed three- and twofold increases in TGF-α gene expression in 20 and 60 day old rats, respectively, after CCl₄. There were 3.5- and 2.5-fold increases in H-ras and 4.4- and 3.4-fold increases in K-ras in 20 and 60 day old rats, respectively. In contrast, a 10-fold increase in c-fos mRNA expression was evident in 20 day old rats 1 hour after CCl₄ treatment, returning to the baseline value by 3 hours, whereas in 60 day old rats, this increase was less than twofold. The overall findings of this study indicate that TGF-α and the early and late proto-oncogene mRNA expressions were enhanced in an age- and time-dependent manner in response to a low dose of CCl₄. These results further strengthen the view that the remarkable resiliency of rats to hepatotoxicants during early postnatal development is due to substantial increases in stimulation of hepatocellular regeneration and tissue repair mechanisms, leading to regression of liver injury and recovery. © 1996 John Wiley & Sons, Inc.     

Role of proto-oncogenes in the regulation of proenkephalin mRNA expression induced by repeated nicotine injections in rat adrenal medulla

We have studied the effect of repeated systemic administrations of nicotine (3 mg/kg) at 30 min intervals on proenkephalin (proENK) mRNA level in rat adrenal gland. Northern blot analysis has shown that proENK mRNA expression was enhanced by repeated nicotine administrations. Additionally, repeated administrations of nicotine transiently induced the c-fos and c-jun mRNA levels after the first-third nicotine administration, and the c-fos and c-jun mRNA levels were returned to the basal level after the seventh administration of nicotine. c-Fos, c-Jun and Fra-2 protein levels were persistently increased until the seventh administration. The repeated nicotine administrations also elevated phospho-CREB without altering total CREB level in all tested groups. Immunohistochemical analysis showed that the increase of c-Fos and c-Jun proteins by repeated nicotine administrations is mostly medulla specific, while Fra-2 immuno reactivity was shown both in medulla and cortex. The repeated nicotine administrations enhanced the AP-1 and ENKCRE-2 DNA binding activities. Furthermore, the cross-competition studies revealed that the AP-1 proteins, rather than CREB, actively bind to ENKCRE-2 DNA domain. These results suggest that proENK mRNA expression induced by repeated nicotine administrations may be mediated by AP-1 proteins, such as c-Fos, c-Jun and Fra-2 rather than CREB via interacting to the ENKCRE-2 DNA binding domain in rat adrenal medulla.     

血管成形术后原癌基因c－fos、c－myc表达的研究

ｃ－ｆｏｓ、ｃ－ｍｙｃ是两种参与细胞增殖的原癌基因。动脉血管成形术（ＰＴＡ）后的血管再狭窄,是由于血管壁平滑肌细胞增生所致。利用大白兔建立的试验动物模型,提取ＰＴＡ后不同时间间隔的动脉壁总ＲＮＡ,并用斑点杂交法分析两种原癌基因的表达情况,发现了ｃ－ｆｏｓ和ｃ－ｍｙｃ的基因分别在术后１５分钟内转录活性提高,并分别在３０分钟和第２小时达到高峰。     

Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features

Fibroadenomas are the most common benign lump in females. The study of gene alterations and/or deregulation in reproductive years may help explain hormonal physiological processes involved in nodule development and evolution. The objective was to compare ER-alpha, c-myc, and bcl-2 gene expression in breast fibroadenomas and in normal tissue and evaluate menstrual cycle, parity, and oral contraceptive influences. Fifty-seven premenopausal women (14-49 years) undergoing surgical removal of fibroadenomas were selected. Samples from fibroadenomas and circumjacent normal tissue were obtained for RT-PCR paired analysis. Patients were divided in groups according to menstrual cycle, use of contraceptives and parity. Tissue from 32 patients was adequate for RT-PCR. Paired analysis showed higher expression of ER-alpha (P=0.012) and bcl-2 (P=0.001) in fibroadenomas than in normal breast, while c-myc presented a similar expression (P=0.655). ER-alpha was higher in fibroadenomas of patients in follicular phase versus contraceptive users and normal tissue (P=0.003); bcl-2 was higher in fibroadenomas of patients in luteal phase than in the normal samples from all groups (P=0.007). c-myc did not differ according to menstrual cycle, but was higher in fibroadenomas>3 cm versus<3 cm (P=0.015) and in nulliparous women (P=0.04). A positive correlation between c-myc levels and fibroadenoma diameter was demonstrated (r=0.536; P=0.007). Nulliparous mean nodule diameter was superior than parous women (P=0.008). In conclusion, the expression of ER-alpha, bcl-2 and c-myc depends on hormonal and reproductive factors, with a possible contribution to lump formation and evolution.     

Paradox of ras Oncogenes in Malignant Melanoma

Our studies over the past several years have concentrated on the role of oncogenes in the pathogenesis of malignant melanoma. Our objectives have been i) to determine the status of oncogene and proto-oncogene activation and expression during specific clinically defined stages of melanoma; ii) to determine if these genes are involved in the induction, maintenance, and/or metastatic potential of melanoma cells; iii) to decipher the relationship of neoplastic transformation to differentiation in this disease; and iv) to determine the nature and timing of specific events which disrupt the normal functioning of the melanocyte. The experiments are intended to test the concept that multiple, cooperating, independently activated oncogenes are involved in the evolution of malignant melanoma. The range of data we have accumulated to date suggests a definite, but complex, role for oncogenes in the development of melanoma and points to a probable interrelatedness of melanocyte-melanoma cellular differentiation programs and the process of malignant transformation. Further, our research has detailed a specific sequence of transformation-related biological and biochemical events occurring in vitro in the human melanocyte in response to ras oncogenes, and has generated information suggesting the presence of, as yet, undefined genetic elements in melanoma. Our work has evolved along a broad front, and we have analyzed the status of a large series of oncogenes in a range of melanomas and related tissues. However, in this brief review we will limit our focus to the ras gene family and discuss the data from my group and others which suggests not only a complex role for ras oncogenes in the etiology of melanoma but also a paradoxical one.